Independent Portfolio Consultants’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Independent Portfolio Consultants’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-45	Closed	-$8K	–	1109
2015 Q1	$8K	Buy	+45	New	+$6.61K	﹤0.01%	740
2014 Q3	–	Sell	-6,305	Closed	-$778K	–	1009
2014 Q2	$778K	Sell	6,305 -980	-13%	-$108K	0.22%	121
2014 Q1	$754K	Sell	7,285 -3,975	-35%	-$407K	0.24%	129
2013 Q4	$1.01M	Buy	11,260 +135	+1%	+$10.8K	0.35%	66
2013 Q3	$744K	Sell	11,125 -220	-2%	-$15.2K	0.3%	99
2013 Q2	$750K	Buy	+11,345	New	+$649K	0.34%	76

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

Independent Portfolio Consultants's SLXP Position: Q2 2015 in Review

Independent Portfolio Consultants sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 45 shares — an estimated $8K sold.

Independent Portfolio Consultants first reported a position in SLXP in Q2 2013 and held it in 6 quarters. The position peaked at $1.01M in Q4 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Independent Portfolio Consultants reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Independent Portfolio Consultants sold 45 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $8K.
Independent Portfolio Consultants first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 6 quarters.
Independent Portfolio Consultants's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.01M in Q4 2013.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Independent Portfolio Consultants's 13F filing for Q2 2015, filed 27 Jul 2015.